Science Times Observer
SEE OTHER BRANDS

Your top news on science and technology

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on June 6, 2025

Sleep Apnea Devices Market worth US$9.3 billion by 2029 | MarketsandMarkets™.

Sleep Apnea Devices Market worth US$9.3 billion by 2029 | MarketsandMarkets™.

Delray Beach, FL, June 06, 2025 (GLOBE NEWSWIRE) -- The global sleep apnea devices market valued at US$6.0 billion in 2023, stood at US$6.5 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a …

Turtle Beach Corporation to Participate in Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference

Turtle Beach Corporation to Participate in Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference

SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Corporation (Nasdaq: TBCH), a leading gaming accessories brand, today announced that Cris Keirn, Chief Executive Officer, and Mark Weinswig, Chief Financial Officer, will virtually participate in …

NetworkNewsAudio Announces Audio Press Release (APR) on Emerging Powerhouse in Gold Industry

NetworkNewsAudio Announces Audio Press Release (APR) on Emerging Powerhouse in Gold Industry

AUSTIN, Texas, June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled " Next Gold Powerhouse Emerges as Prices Break Records," featuring ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF). To hear the …

iPower Launches New Joint Venture, United Package NV LLC

iPower Launches New Joint Venture, United Package NV LLC

RANCHO CUCAMONGA, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce services provider and online retailer, today announced the formation of United Package NV LLC (“United …

Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors

Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors

NEEDHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Douglas Dynamics Declares Quarterly Cash Dividend

Douglas Dynamics Declares Quarterly Cash Dividend

MILWAUKEE, June 06, 2025 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE: PLOW), North America's premier manufacturer and upfitter of work truck attachments and equipment, today announced that its Board of Directors approved and declared a quarterly cash …

Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors

Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors

HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Denice M. Torres has been elected to the company’s Board of Directors. "We are excited to welcome Denice to the Celldex Board of Directors," said …

Entrée Resources Announces Pause in Oyu Tolgoi Lift 1 Panel 1 Underground Development Work

Entrée Resources Announces Pause in Oyu Tolgoi Lift 1 Panel 1 Underground Development Work

VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) announces the Entrée/Oyu Tolgoi joint venture (the “Entrée/Oyu Tolgoi JV” or “JV”) has paused Oyu Tolgoi Lift 1 Panel 1 …

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …

Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting

Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting

Data show SPR301 lowered α-synuclein, a hallmark of Parkinson’s disease, in cellular models, indicating potential for efficacy at doses with favorable safety Demonstrated greater α-synuclein reductions compared to other gene therapy approaches LONDON, June …

TERRA BALCANICA ANNONCE UNE EXTENSION DE PLACEMENT FONDÉ SUR LA DISPENSE POUR FINANCEMENT DE L’ÉMETTEUR COTÉ

TERRA BALCANICA ANNONCE UNE EXTENSION DE PLACEMENT FONDÉ SUR LA DISPENSE POUR FINANCEMENT DE L’ÉMETTEUR COTÉ

NE PAS DIFFUSER AUX ÉTATS-UNIS OU PAR L’INTERMÉDIAIRE DES SERVICES D’INFORMATION DES ÉTATS-UNIS Vancouver, Colombie-Britannique, 06 juin 2025 (GLOBE NEWSWIRE) --  Terra Balcanica Resources Corp. (« Terra » ou la « Société ») (CSE : TERA; FRA : UB1) annonce …

Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference

Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference

New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or minimal itch with ZORYVE cream 0.15% or ZORYVE cream 0. …

American Rebel CEO to Perform at Bristol Dragway and American Rebel Light Beer to be Featured at Trackside Bar and Beer Garden

American Rebel CEO to Perform at Bristol Dragway and American Rebel Light Beer to be Featured at Trackside Bar and Beer Garden

PATRIOTISM MEETS HORSEPOWER: ANDY ROSS TO IGNITE BRISTOL DRAGWAY WITH ELECTRIFYING PERFORMANCE! NASHVILLE, TN, June 06, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on June …

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, …

FuelCell Energy Reports Second Quarter of Fiscal 2025 Results

FuelCell Energy Reports Second Quarter of Fiscal 2025 Results

Second Quarter Fiscal 2025 Summary (All comparisons are year-over-year unless otherwise noted) Revenue of $37.4 million, compared to $22.4 million, an increase of approximately 67% Gross loss of $(9.4) million compared to $(7.1) million, an increase of …

Functional Safety Market Size expected to reach US$ 13.00 billion by 2031, Experiences Growth Owing to Increased Automation Across Industries | The Insight Partners

Functional Safety Market Size expected to reach US$ 13.00 billion by 2031, Experiences Growth Owing to Increased Automation Across Industries | The Insight Partners

US …

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 …

Changes in Nokia Corporation's own shares

Changes in Nokia Corporation's own shares

Nokia Corporation Stock Exchange Release 6 June 2025 at 14:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 129 878 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia' …

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Nokia Oyj Pörssitiedote 6.6.2025 klo 14.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 129 878 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service